Sunday, April 4, 2021

Zydus Cadila witness promising results in Phase 3 clinical trials of PegIFN, seeks DGCI approval for Covid treatment

Promising Interim results from Phase III clinical trials with Pegylated Interferon alpha2b in COVID-19 show higher clinical improvemt.

from India Infoline News Service https://ift.tt/2Ors0Qw
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)